Skip to content
Lower risk Medical device recall · FDA · Published May 17, 2021

Cytocell DiGeorge Probe Recall: Unexpected signals in genetic testing

Cytocell recalls DiGeorge/VCFS TUPLE1 Region and 22q13.3 Region Probe (Model LPU004-A) due to potential for unexpected genetic signals in testing. Affected lots: 071399, 072985.

🇺🇸 FDA recall #Z-2134-2021Medical deviceCytocell ›
Take action

Contact the company

Recalling firmCytocell Ltd.418 Cambridge Science Park, Milton Road, Oxford Gene Technology · Cambridge, United Kingdom
✎ GovInfoNow plain-language explainer

Cytocell is recalling a genetic testing probe that may show unexpected signals during analysis. This could lead to inaccurate results in DiGeorge/VC:FS syndrome testing. Affected units have specific lot numbers. Read more at govinfonow.com/recall/62536-cytocell-digeorge-probe-recall-unexpected-signals-in-genetic-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/62536-cytocell-digeorge-probe-recall-unexpected-signals-in-genetic-testing · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2134-2021

Cite this page

“Cytocell DiGeorge Probe Recall: Unexpected signals in genetic testing.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62536-cytocell-digeorge-probe-recall-unexpected-signals-in-genetic-testing. Based on FDA recall #Z-2134-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2134-2021%22&limit=1).

The FDA announced on May 17, 2021, that Cytocell Ltd. voluntarily recalled the CytoCell DiGeorge/VCFS TUPLE1 Region and 22q13.3 Region Probe, Model Number LPU004-A. The device may show unexpected locus-specific signals, potentially leading to incorrect diagnostic results.

How to tell if you have it

  • Brand: Cytocell
  • Product: CytoCell DiGeorge/VCFS TUPLE1 Region and 22q13.3 Region Probe
  • Model Number: LPU004-A
  • Lot Numbers: 071399, 072985
  • Quantity: 50 units

The hazard

The device may show unexpected locus-specific signals in addition to those at 22q. Users may observe faint additional locus-specific signals at 20p12/13.

Context

GovInfoNow's records show Cytocell Ltd. has had 12 other recalls since March 15, 2019. Recent brand recalls include a May 24, 2023 recall for RET Proximal Probe due to DNA inversion risk and two October 27, 2022 recalls for BCL11B Reagent and Proximal Probe involving chromomap errors and mislabeling. Other recent recalls of similar products include Exploro Fertility Test Recall (Nov. 22, 2025), Changchun Wancheng Male Fertility Sperm Test Cassette Recall (Nov. 22, 2025), and Changchun Wancheng Bio-Electron UTI Test Strips Recall (Nov. 22, 2025).

How to tell if you have this one

Check if you have the Cytocell DiGeorge/VCFS TUPLE1 Region and 22q13.3 Region Probe with model number LPU004-A. Look for lot numbers 071399 or 072985 on the packaging.

  • Brand
    Cytocell
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Number

    Look for lot numbers 071399 or 072985 on the probe packaging.

Where it went and when

Where it was distributed

Distributed in 7 states, and outside the U.S.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: yesPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: yesUTColorado: not listedCONebraska: not listedNEMissouri: yesMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “Distribution to US states of CA, IL, MO, NY, PA, TX, and UT, and Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Illinois, Missouri, New York, Pennsylvania, Texas, Utah.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: May 17, 202112. FDA classified it Class II: Jul 23, 202123. Published in FDA’s Enforcement Report: Aug 4, 202134. FDA terminated the recall: Aug 15, 2022420212022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2134-2021 (May 17, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2134-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA